Literature DB >> 2072800

Surgical treatment of peptic ulcer disease.

A K Sachdeva1, H A Zaren, B Sigel.   

Abstract

Elective surgery for peptic ulcer disease has diminished significantly over the past 15 years. However, emergency surgery has not shown a decline. Some series have even reported an increase in hospitalizations and operations for hemorrhage. The appropriate surgical procedure for peptic ulcer disease must be tailored to the specific needs of the individual patient. During emergency operations for hemorrhage from duodenal ulcer, we recommend suture ligature of the bleeding vessel and vagotomy-pyloroplasty for high-risk patients, or vagotomy-antrectomy for the lower-risk patient. Bleeding gastric ulcers should be resected, if possible. For massive hemorrhage from stress ulceration requiring surgery, near-total or total gastrectomy should be performed. Perforated duodenal ulcers are best managed by closure and a definitive ulcer operation, such as vagotomy-pyloroplasty. Perforated gastric ulcers are best excised but may be simply closed if conditions do not favor resection. In these situations, biopsy should be performed. We recommend truncal vagotomy-antrectomy for patients presenting with obstruction. Vagotomy (truncal or proximal gastric) with drainage is an acceptable alternative in this situation. For patients with intractable ulcer disease or for those who are noncompliant, proximal gastric vagotomy is the preferred operation. However, other operations may need to be considered, depending on the specific situation. Recurrent ulceration needs appropriate work-up to determine the possible cause. Although patients with ulcer recurrence initially may be placed on medical treatment, about 50% will require reoperation. The most effective procedure for peptic ulcer disease is truncal vagotomy-antrectomy, which has a recurrence rate of less than 1%. The procedure with the least morbidity and the fewest undesirable side effects is proximal gastric vagotomy. Ulcer recurrence after proximal gastric vagotomy or truncal vagotomy-pyloroplasty is in the range of 10% to 15%.

Entities:  

Mesh:

Year:  1991        PMID: 2072800     DOI: 10.1016/s0025-7125(16)30426-6

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  8 in total

1.  Duodenal tamponade in the treatment of an intractable peptic ulcer bleed.

Authors:  A Rohatgi; P W Houghton
Journal:  Ann R Coll Surg Engl       Date:  2001-09       Impact factor: 1.891

2.  Segmental duodenal resection: indications, surgical techniques and postoperative outcomes.

Authors:  D Dorcaratto; H M Heneghan; B Fiore; F Awan; D Maguire; J Geoghegan; K Conlon; E Hoti
Journal:  J Gastrointest Surg       Date:  2015-01-17       Impact factor: 3.452

Review 3.  Impact of gastric and bowel surgery on gastrointestinal drug delivery.

Authors:  Susan Hua; Ephraem C Lye
Journal:  Drug Deliv Transl Res       Date:  2022-05-18       Impact factor: 4.617

4.  Long-term clinical results of highly selective vagotomy performed between 1980 and 1990.

Authors:  M Ihász; J Bátorfi; A Bálint; T Fazekas; M Máté; G Pòsfai; J Sándor
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

5.  A life-saving but inadequately discussed procedure: tube duodenostomy. Known and unknown aspects.

Authors:  Burak Isik; Sezai Yilmaz; Vedat Kirimlioglu; Gokhan Sogutlu; Mehmet Yilmaz; Daniel Katz
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

6.  Changes in surgical strategies for peptic ulcers before and after the introduction of H2-receptor antagonists and endoscopic hemostasis.

Authors:  M Ishikawa; S Ogata; M Harada; Y Sakakihara
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

7.  Laparoscopic gastrojejunostomy for the treatment of gastric outlet obstruction.

Authors:  Linda P Zhang; Parissa Tabrizian; Scott Nguyen; Dana Telem; Celia Divino
Journal:  JSLS       Date:  2011 Apr-Jun       Impact factor: 2.172

8.  Gastric outlet obstruction at Bugando Medical Centre in Northwestern Tanzania: a prospective review of 184 cases.

Authors:  Hyasinta Jaka; Mabula D Mchembe; Peter F Rambau; Phillipo L Chalya
Journal:  BMC Surg       Date:  2013-09-25       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.